Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Early research (Phase 1)Looking for participantsNCT05631886
What this trial is testing

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Who this might be right for
Solid Tumor, AdultLymphomaEphA2 Overexpression+4 more
Chinese PLA General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00521144
What this trial is testing

Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors

Who this might be right for
Recurrent Small Cell Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 22
Early research (Phase 1)Active Not RecruitingNCT04891757
What this trial is testing

FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Advanced Hematologic MalignancyRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+4 more
Foghorn Therapeutics Inc. 144
Early research (Phase 1)Looking for participantsNCT05607498
What this trial is testing

First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

Who this might be right for
Advanced/Metastatic Solid TumorsRelapse/Refractory Lymphoma
EpimAb Biotherapeutics (Suzhou)Co., Ltd. 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04067336
What this trial is testing

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Advanced Malignant NeoplasmAcute Myeloid LeukemiaMixed Lineage Leukemia+4 more
Kura Oncology, Inc. 263
Testing effectiveness (Phase 2)Study completedNCT02546544
What this trial is testing

Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma

Who this might be right for
Relapsed Ewing SarcomaRefractory Ewing Sarcoma
University of Oxford 16
Early research (Phase 1)Study completedNCT00002890
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT00185679
What this trial is testing

Haploid Allogeneic Transplant Using the CliniMACS System

Who this might be right for
Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk FactorsChronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic PhaseMyelodysplastic Syndrome (MDS) - High and Intermediate Risk+2 more
Ginna Laport 13
Testing effectiveness (Phase 2)Ended earlyNCT05721222
What this trial is testing

Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

Who this might be right for
Renal Cell CarcinomaNasopharyngeal CarcinomaNon Hodgkin Lymphoma
Genmab 42
Early research (Phase 1)Ended earlyNCT04438083
What this trial is testing

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Who this might be right for
Renal Cell Carcinoma
CRISPR Therapeutics AG 19
Early research (Phase 1)Study completedNCT02909972
What this trial is testing

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Aileron Therapeutics, Inc. 55
Early research (Phase 1)Study completedNCT01844869
What this trial is testing

An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Who this might be right for
Hematologic MalignanciesSolid Tumors
Teva Branded Pharmaceutical Products R&D, Inc. 6
Early research (Phase 1)Study completedNCT00925275
What this trial is testing

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumors
Cellectar, Inc 9
Early research (Phase 1)Ended earlyNCT02313012
What this trial is testing

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Who this might be right for
Neoplasm Metastasis
Celgene 19
Early research (Phase 1)Study completedNCT03099109
What this trial is testing

LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumor
Eli Lilly and Company 209